Current Issue cover

J&J Presents on Skin Health, Oncology Care, Emotions/Acne and Sunscreens at AAD

Contact Author Michele Behrens
Fill out my online form.

"Our deep knowledge of the therapeutic benefits of oat led us to believe an oat daily skin care regimen can help replenish the skin barrier in cancer patients who experience xerosis and pruritus due to systemic oncological treatment."


Johnson & Johnson (J&J) Consumer Health presented research including a study on restorative skin care for cancer patients, advances in multicultural skin care, the emotional impact of acne and more during the American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX).

Featured: Topical Avena sativa Improves Skin Health in Adults Undergoing Cancer Treatment

The virtual meeting was held on April 23-25, 2021, where J&J featured a total of 13 posters and three oral presentations, including:

  • Presentation #26630: The Role of Skin Barrier in Cutaneous Adverse Drug Reactions in Oncology Therapy and the Benefit of Topical Emollients;
  • Presentation #26634: Insights into the Mechanisms of EGFRi-induced Cutaneous Adverse Drug Reactions From Functional Phospho-proteomic and Transcriptomic Data; and
  • Presentation #27031: Sunscreens Designed and Validated by Consumers to be "Invisible on All Skin Tones."

"Sun protection including sunscreen is vital for everyone to protect their skin from sun damage and help prevent skin cancer,” said Barbara Green, senior director of skin health translational science at J&J. “However, a common misconception is that Black and Brown communities do not benefit from sunscreen. We formulated products specifically to be invisible on the skin while feeling weightless and breathable." She added J&J was pleased to present the results of a one-week consumer experience study of 160 consumers representing all Fitzpatrick skin types and ethnicities, equally.

According to the company, through its scientific process, J&J brings skin care products to consumers and health care professionals worldwide. Its recent skin care innovations include: Neutrogena's patented Rapid Firming Peptide Contour Lift Cream, which features a proprietary matrix-building dipeptide to reduce the look of fine lines and specifically target five anti-sagging markers in the skin. Also, Aveeno's Restorative Skin Therapy line, a three-step regimen clinically proven to be effective on xerosis and pruritus in adult oncology patients. Finally, Neutrogena Invisible Daily Defense sunscreens, reported to be "invisible on all skin tones."

Related: BASF Formulates ‘Moisture and Mattification for Melanated Skin’

Other J&J poster presentations included:

  • Poster #27891: Safety and Efficacy of an Avena Sativa (Oat) Skin Care Regimen for Therapy Related Xerosis and Pruritus in Adult Oncology Patients Undergoing Systemic Cancer Treatments;
  • Poster #25399: A 1% Colloidal Oatmeal OTC Cream is Clinically Effective for the Management of Mild to Moderate Atopic Dermatitis in African American Children;
  • Poster #25789: Profiling Acne Sufferers: From Acne Types/Severity to Impact on Personal and Social Life;
  • Poster #27027: Mitigation of Damage Induced by Environmental Pollution by Feverfew Extract;
  • Poster #27892: Tolerance and Effectiveness of a Gel Cream Containing Oat and Feverfew on Capsaicin Sting-Positive Dry Sensitive Skin;
  • Poster #27893: An Advanced Oil Composition Containing Stabilized Retinol With Enhanced Bioactivity;
  • Poster #27885: An Optimized Formulation of Retinol With a Specific Sensory Profile Upregulates Anti-Aging Biomarkers for Both Prevention and Rejuvenation of the Skin;
  • Poster #27884: A Multi-Center Clinical Study to Evaluate the Efficacy and Tolerance of a Benzoyl Peroxide and Retinol Regimen in the Treatment of Mild to Moderate Acne Vulgaris;
  • Poster #27886: Optimized Delivery of a Novel Acetyl Dipeptide Provides Clinical and Consumer Perceivable Benefits to Anti-aging Attributes of the Lower Face, Including Firming and Jawline Contour;
  • Poster #27887: Skin Exfoliation with Low Concentrations of Alpha Hydroxy Acids and Poly Hydroxy Acids when Incorporated into Wash-off or Leave-on Products Using a Novel Abbreviated Model to Measure Cell Turnover Rate;
  • Poster #26619: Appropriateness of a Novel, Low pH, 2% Polyhydroxy Acid Facial Cleanser for Patients with Dry and Sensitive Skin;
  • Poster #27890: Chelation Properties Demonstrated by a Novel Analytical Method Help Elucidate Polyhydroxy Acids Benefits for Environmental Oxidative Stress and Pigmentation; and
  • Poster #28140: How a Lotion with Prebiotic Yeast Extract Regulates the Environmental Aggressors Impact on the Skin Microbiome.

"Cancer patients undergoing treatment frequently report negative skin-related side effects such as xerosis and pruritus, or dry skin and itch, yet few studies are evaluating potential remedies," noted Georgios Stamatas, Ph.D., research associate director and fellow of J&J Consumer Health. "Our deep knowledge of the therapeutic benefits of oat led us to believe an Avena sativa (oat) daily skin care regimen can help replenish the skin barrier in cancer patients who experience xerosis and pruritus due to systemic oncological treatment." He added the company was excited to share the results of this study at the AAD event.

"At Johnson & Johnson Consumer Health, we pride ourselves on developing innovative solutions through next-generation science for healthier skin," said Caroline Tillett, global head of R&D of J&J Consumer Health. "Over the past year, we made substantial advancements in critical research programs that will support major consumer health needs. Our research with cancer patients, acne sufferers and diverse communities demonstrates our unwavering commitment to provide skin care options across the spectrum of skin types, tones and needs."

Previously: Johnson & Johnson Committing $800M for Sustainability of Brands



Next image >